Xeroderma pigmentosum A (Q92835): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Xeroderma pigmentoso do grupo de complementação A (XPA) é uma forma grave de xeroderma pigmentoso (XP), uma fotodermatose rara que predispõe a cânceres de pele e mostra manifestações XP típicas (fotossensibilidade da pele com queimadura, sardas e cânceres de pele) associada a um espectro de anomalias neurológicas leves a graves (p.ex., deterioração cognitiva, disartria, distúrbio do equilíbrio, arreflexia) e, às vezes, retardo do crescimento e do desenvolvimento sexual.
description / endescription / en
 
Xeroderma pigmentosum complementation group A (XPA) is a severe form of xeroderma pigmentosum (XP), a rare photodermatosis predisposing to skin cancers, and shows typical XP manifestations (photosensitivity of skin with burning, freckling, and skin cancers) associated with a spectrum of mild to severe neurological anomalies (e.g. cognitive deterioration, dysarthria, balance disturbance, areflexia) and sometimes delay of growth and sexual development.

Revision as of 07:57, 16 August 2026

Xeroderma pigmentosum complementation group A (XPA) is a severe form of xeroderma pigmentosum (XP), a rare photodermatosis predisposing to skin cancers, and shows typical XP manifestations (photosensitivity of skin with burning, freckling, and skin cancers) associated with a spectrum of mild to severe neurological anomalies (e.g. cognitive deterioration, dysarthria, balance disturbance, areflexia) and sometimes delay of growth and sexual development.
Language Label Description Also known as
default for all languages
ID_502959160
    English
    Xeroderma pigmentosum A
    Xeroderma pigmentosum complementation group A (XPA) is a severe form of xeroderma pigmentosum (XP), a rare photodermatosis predisposing to skin cancers, and shows typical XP manifestations (photosensitivity of skin with burning, freckling, and skin cancers) associated with a spectrum of mild to severe neurological anomalies (e.g. cognitive deterioration, dysarthria, balance disturbance, areflexia) and sometimes delay of growth and sexual development.

      Statements